InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Ribeiro Ramiro. Director active across 2 companies, notably EyePoint, Inc.. In total, 7 reports have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €58k. History available since 11 November 2025. The latest transaction was disclosed on 17 April 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
7 of 7 declarations
Ribeiro Ramiro is a declarant with 7 filings in total. Across the 7 sampled recent filings between 2025-11-12 and 2026-04-20, sales total 58369 EUR and the most frequent transaction nature is Levée d'options. He is Chief Medical Officer at EyePoint, Inc. and EyePoint Pharmaceuticals, Inc.